Corrigendum to “Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety” Biomed. Pharmacother. 108 (2018) 1274–1281 - 23/07/24
Doi : 10.1016/j.biopha.2024.116945
Bhavesh C. Variya a, Anita K. Bakrania a, Yuanli Chen b, Jihong Han c, Snehal S. Patel a, ⁎ 
a Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
b Collaborative Innovation Center of Biotherapy, School of Medicine, Nankai University, Tianjin 300071, China
c College of Life Sciences, Nankai University, Tianjin 300071, China
⁎Correspondence to: Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382481, India.Department of Pharmacology, Institute of Pharmacy, Nirma UniversityAhmedabadGujarat382481India
Le texte complet de cet article est disponible en PDF.
© 2024
Elsevier Masson SAS. Tous droits réservés.
Vol 177
Article 116945- août 2024 Retour au numéro
Article précédent
- Corrigendum to “Development and functional evaluation of a hyaluronic acid coated nano-formulation with kaempferol as a novel intra-articular agent for knee osteoarthritis treatment”[ Biomed. Pharmacother. 175(2024) 116717]
- Ching-Yu Lee, Yu-Chu Chang, Kai-Chiang Yang, Yung-fang Lin, Alexander T.H. Wu, Ching-Li Tseng
- Corrigendum to “MicroRNA-24-1 suppresses mouse hepatoma cell invasion and metastasis via directly targeting O-GlcNAc transferase” [Biomed. Pharmacother., vol. 91 (July 2017) Pages 731–738/BIOPHA 5337]
- Yubo Liu, Huang Huang, Meijun Liu, Qiong Wu, Wenli Li, Jianing Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?